Technical Analysis for LUMO - Lumos Pharma, Inc.

Grade Last Price % Change Price Change
A 4.37 -1.58% -0.07
LUMO closed down 1.58 percent on Friday, November 1, 2024, on 20 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Nov 5
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
180 Bullish Setup Bullish Swing Setup -1.58%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.58%
Overbought Stochastic Strength -1.58%
Stochastic Sell Signal Bearish 0.69%
Overbought Stochastic Strength 0.69%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%

   Recent Intraday Alerts

Alert Time
Down 1% about 21 hours ago
Possible NR7 about 21 hours ago
Bullish 180 Entry about 24 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 24 hours ago
Rose Above Previous Day's High about 24 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lumos Pharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for severe, rare, and genetic diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone stimulating small molecule, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency. The company has a licensing agreement with Ellipses Pharma Limited for the development of and rights to commercialize nanoparticle formulations of two therapeutics for oncology indications. Lumos Pharma, Inc. was founded in 2011 and is headquartered in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmacy Genetic Diseases Growth Hormone Growth Hormone Deficiency Growth Hormone Therapy

Is LUMO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.5756
52 Week Low 1.3701
Average Volume 92,752
200-Day Moving Average 2.90
50-Day Moving Average 3.91
20-Day Moving Average 4.08
10-Day Moving Average 4.28
Average True Range 0.24
RSI (14) 60.16
ADX 15.16
+DI 19.58
-DI 14.90
Chandelier Exit (Long, 3 ATRs) 3.84
Chandelier Exit (Short, 3 ATRs) 4.17
Upper Bollinger Bands 4.61
Lower Bollinger Band 3.55
Percent B (%b) 0.78
BandWidth 25.97
MACD Line 0.19
MACD Signal Line 0.16
MACD Histogram 0.0246
Fundamentals Value
Market Cap 34.59 Million
Num Shares 7.91 Million
EPS -3.99
Price-to-Earnings (P/E) Ratio -1.10
Price-to-Sales 13.74
Price-to-Book 0.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.57
Resistance 3 (R3) 4.58 4.54 4.53
Resistance 2 (R2) 4.54 4.49 4.53 4.52
Resistance 1 (R1) 4.45 4.46 4.43 4.44 4.51
Pivot Point 4.41 4.41 4.40 4.40 4.41
Support 1 (S1) 4.32 4.36 4.30 4.31 4.23
Support 2 (S2) 4.28 4.33 4.27 4.22
Support 3 (S3) 4.19 4.28 4.21
Support 4 (S4) 4.18